Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Shamash

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Cancer Medicine|May 20, 2026
Clinical Outcomes of the Alternative GAMMA Regimen in Relapsed Germ Cell TumoursNasreen Abdul Aziz, Kenrick Ng, Prabhakar Rajan, et al.
Scottish Medical Journal|May 5, 2022
Management of stage II seminoma: a contemporary UK perspectiveConstantine Alifrangis, David L Nicol, Jonathan Shamash, et al.
Histopathology|December 14, 2016
Postchemotherapy changes in testicular germ cell tumours: biology and morphologyDaniel M Berney, Yong-Jie Lu, Jonathan Shamash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Prognostic factors in cytokine-refractory renal cell carcinoma treated with irinotecan, Cisplatin, and mitomycin chemotherapyJonathan Shamash, Tom Powles, Peter Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2021
Re: 'Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis'Michelle Lockley, Sara Stoneham, Jonathan Shamash, et al.
JCO Oncology Practice|April 16, 2024
Prostate Cancer Survivorship and Global Health-Related Quality of LifeEdward Christopher Dee, Kenrick Ng, Jonathan Shamash, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2021
Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in EnglandKenrick Ng, Peter Wilson, Katherine Mutsvangwa, et al.
The American Journal of Surgical Pathology|September 15, 2005
The frequency and distribution of intratubular trophoblast in association with germ cell tumors of the testisDaniel M Berney, Abigail Lee, Jonathan Shamash, et al.
Human Pathology|March 28, 2006
The association between intratubular seminoma and invasive germ cell tumorsDaniel M Berney, Abigail Lee, Jonathan Shamash, et al.
American Journal of Cancer Research|September 21, 2016
Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatinAhmet Imrali, Xueying Mao, Marc Yeste-Velasco, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Cancer Medicine|May 20, 2026
Clinical Outcomes of the Alternative GAMMA Regimen in Relapsed Germ Cell TumoursNasreen Abdul Aziz, Kenrick Ng, Prabhakar Rajan, et al.
Scottish Medical Journal|May 5, 2022
Management of stage II seminoma: a contemporary UK perspectiveConstantine Alifrangis, David L Nicol, Jonathan Shamash, et al.
Histopathology|December 14, 2016
Postchemotherapy changes in testicular germ cell tumours: biology and morphologyDaniel M Berney, Yong-Jie Lu, Jonathan Shamash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Prognostic factors in cytokine-refractory renal cell carcinoma treated with irinotecan, Cisplatin, and mitomycin chemotherapyJonathan Shamash, Tom Powles, Peter Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2021
Re: 'Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis'Michelle Lockley, Sara Stoneham, Jonathan Shamash, et al.
JCO Oncology Practice|April 16, 2024
Prostate Cancer Survivorship and Global Health-Related Quality of LifeEdward Christopher Dee, Kenrick Ng, Jonathan Shamash, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2021
Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in EnglandKenrick Ng, Peter Wilson, Katherine Mutsvangwa, et al.
The American Journal of Surgical Pathology|September 15, 2005
The frequency and distribution of intratubular trophoblast in association with germ cell tumors of the testisDaniel M Berney, Abigail Lee, Jonathan Shamash, et al.
Human Pathology|March 28, 2006
The association between intratubular seminoma and invasive germ cell tumorsDaniel M Berney, Abigail Lee, Jonathan Shamash, et al.
American Journal of Cancer Research|September 21, 2016
Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatinAhmet Imrali, Xueying Mao, Marc Yeste-Velasco, et al.
Pageof 11